DrugDashboards

Vancomycin Hydrochloride

Vancomycin Hydrochloride · VANCOMYCIN HYDROCHLORIDE 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Hospira, Inc.

NDC 00409-6509-01 · 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE · ANDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. The price has jumped 39% in a year, to $39.32 per unit — sharp rises like this often mean supply is already tightening. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$39.32per EAinvoice-surveyed acquisition cost · Sep 18, 2024
  • Medicare Part B pays (ASP+6%)$0.0330per billing unit (10 MG)HCPCS J3373 · Jul 1, 2026
  • Federal contracts pay (FSS)$17.98per unitPfizer Inc. · Jul 1, 202446% of what pharmacies pay — a deeper discount than 90% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$20.00$40.00$60.00Nov 2013Sep 2024$39.32
20 price points · per EA · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$90.26
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.033
HCPCS J3373 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$405,369
5,229 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for vancomycin hydrochloride (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

  • Hospira, Inc.United States
    analysis · label · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA063076
TE code
AP
Approval date
Dec 21, 1990
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)Nov 14, 2025

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Vancomycin Hydrochloride (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 750 mg/15mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 10 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 5 g/100mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 3, 2026
Fresenius Kabi, LLCVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 3, 2026
Hospira, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesVANCOMYCIN HYDROCHLORIDE 5 g/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesVANCOMYCIN HYDROCHLORIDE 10 g/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.VANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Civica, IncVANCOMYCIN HYDROCHLORIDE 1 g/1Jul 15, 2026Sep 2, 2026
Civica, IncVANCOMYCIN HYDROCHLORIDE 500 mg/5mLJul 15, 2026Sep 2, 2026
Civica, IncVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 1.5 g/30mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 5 g/1Jul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 1.25 g/25mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Eugia US LLCVANCOMYCIN HYDROCHLORIDE 10 g/1Jul 15, 2026Sep 2, 2026
Eurofarma, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Eurofarma, Inc.VANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Fresenius Kabi, LLCVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Fresenius Kabi, LLCVANCOMYCIN HYDROCHLORIDE 10 g/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 1.5 g/1Jul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 10 g/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 1.25 g/1Jul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 5 g/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedVANCOMYCIN HYDROCHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 1.5 g/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 1 g/20mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 1.25 g/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., UsaVANCOMYCIN HYDROCHLORIDE 500 mg/10mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.VANCOMYCIN HYDROCHLORIDE 500 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN HYDROCHLORIDE 1.5 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN HYDROCHLORIDE 1.25 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 750 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vancomycin Hydrochloride — NDC 00409-6509-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00409650901.

Free to cite with attribution — see how the data is put together.